[1]
M. M. Botelho, E. L. Lopes, M. C. M. Paredes, T. T. Martins, and G. B. Melara, “THE USE OF GLP-1 RECEPTOR AGONISTS IN IMMUNOCOMPROMISED OR IMMUNOSUPPRESSED PATIENTS”, REASE, vol. 12, no. 9, pp. 1–13, Sep. 2026, doi: 10.51891/rease.v12i9.28426.